Connect with us


NDoH takes precautionary measures in light of new findings on Johnson & Johnson vaccine

Published on

The NDoH has announced the indefinite halt of the Sisonke rollout plan, following findings that the Johnson & Johnson vaccine has caused blood clots in six women from the US.

Minister of Health, Dr Zweli Mkhize took to Twitter on Tuesday, 13 April 2021, to announce that the National Department of Health (NDoH) has decided to halt the Sisonke vaccination rollout programme indefinitely. The announcement comes on the back of the Food and Drug Administration (FDA) in the United States (US) announcing that it has found that the Johnson & Johnson vaccine has been linked to causing severe blood clots in six women from the US.

The precautionary measure has been widely welcomed, however, it marks yet another delay in the already staggered rollout plan. Moreover, should the Johnson & Johnson vaccine prove unusable, it will have a long-reaching impact on the economy too. The country, in partnership with the Aspen Pharmaceutical company, has funded the local manufacturing of the Johnson and Johnson vaccine.

Additionally, the South African Health Products Regulatory Authority (SAHPRA) recently confirmed the registration of the vaccine. Now, the production thereof is expected to be halted too, in light of the FDA’s findings.

See the post below.

Sabelo Makhubo
[email protected]

Copyright © 2021 Political Analysis South Africa

error: Copyrighted Content